UY27399A1 - Proceso para la preparación de quinazolinas - Google Patents
Proceso para la preparación de quinazolinasInfo
- Publication number
- UY27399A1 UY27399A1 UY27399A UY27399A UY27399A1 UY 27399 A1 UY27399 A1 UY 27399A1 UY 27399 A UY27399 A UY 27399A UY 27399 A UY27399 A UY 27399A UY 27399 A1 UY27399 A1 UY 27399A1
- Authority
- UY
- Uruguay
- Prior art keywords
- formula
- ring
- compound
- quinazolins
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Proceso para la producción de un compuesto de fórmula (A), o una sal o solvato farmacéuticamente aceptable del mismo, comprendiendo el proceso condensar unos compuestos de fórmula (B), con un compuesto de fórmula (C) en la que R5 y R6, tomados conjuntamente con el átomo de N al que están unidos, representan un anillo heterocíclico que contiene N de 4, 5, 6 o 7 miembros, estando opcionalmente condensado el anillo con un anillo de benceno o un anillo heterocíclico de 5 o 6 miembros, estando opcionalmente sustituido el sistema de anillo en conjunto.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0118752.5A GB0118752D0 (en) | 2001-08-01 | 2001-08-01 | Process for the production of quinazolines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY27399A1 true UY27399A1 (es) | 2003-02-28 |
Family
ID=9919612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY27399A UY27399A1 (es) | 2001-08-01 | 2002-07-29 | Proceso para la preparación de quinazolinas |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US7026479B2 (es) |
| EP (1) | EP1412331B1 (es) |
| JP (1) | JP2005501054A (es) |
| KR (1) | KR20040019097A (es) |
| CN (1) | CN1533378A (es) |
| AP (1) | AP1299A (es) |
| AR (1) | AR036204A1 (es) |
| AT (1) | ATE323677T1 (es) |
| BR (1) | BR0211670A (es) |
| CA (1) | CA2451075A1 (es) |
| CZ (1) | CZ2004151A3 (es) |
| DE (1) | DE60210778T2 (es) |
| DO (1) | DOP2002000443A (es) |
| EG (1) | EG23204A (es) |
| ES (1) | ES2260457T3 (es) |
| GB (1) | GB0118752D0 (es) |
| HN (1) | HN2002000197A (es) |
| HU (1) | HUP0401573A3 (es) |
| IL (1) | IL158998A0 (es) |
| MX (1) | MXPA04000978A (es) |
| PA (1) | PA8550301A1 (es) |
| PE (1) | PE20030346A1 (es) |
| PL (1) | PL368520A1 (es) |
| RU (1) | RU2261861C1 (es) |
| UY (1) | UY27399A1 (es) |
| WO (1) | WO2003011829A1 (es) |
| ZA (1) | ZA200309043B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1521747B1 (en) | 2002-07-15 | 2018-09-05 | Symphony Evolution, Inc. | Receptor-type kinase modulators and methods of use |
| CA2537812C (en) | 2003-09-26 | 2013-01-22 | Exelixis, Inc. | C-met modulators and method of use |
| ME01267B (me) | 2004-05-06 | 2013-06-20 | Warner Lambert Co | 4-fenilaminokinazolin-6-ilamidi |
| TW200823215A (en) * | 2006-08-04 | 2008-06-01 | Merz Pharma Gmbh & Amp Co Kgaa | Pyrazolopyrimidines, a process for their preparation and the use as a medicine |
| CA2995880C (en) | 2009-01-16 | 2021-01-05 | Exelixis, Inc. | Processes for preparing n-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide |
| BRPI1009315B8 (pt) | 2009-03-18 | 2021-05-25 | Resverlogix Corp | composto anti-flamatórios e suas composições farmacêuticas |
| IN2012DN00352A (es) * | 2009-06-16 | 2015-08-21 | Bikam Pharmaceuticals Inc | |
| UA108618C2 (uk) | 2009-08-07 | 2015-05-25 | Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку | |
| AU2012346214B2 (en) * | 2011-11-30 | 2017-09-14 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
| NZ707276A (en) * | 2012-10-15 | 2016-02-26 | Resverlogix Corp | Compounds useful in the synthesis of benzamide compounds |
| US10111885B2 (en) | 2015-03-13 | 2018-10-30 | Resverlogix Corp. | Compositions and therapeutic methods for the treatment of complement-associated diseases |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8719378D0 (en) * | 1987-08-15 | 1987-09-23 | Pfizer Ltd | Antiarrythmic agents |
| EP0894797A4 (en) * | 1997-01-09 | 2001-08-16 | Terumo Corp | NEW AMID DERIVATIVES AND INTERMEDIATES ON YOUR SYNTHESIS |
-
2001
- 2001-08-01 GB GBGB0118752.5A patent/GB0118752D0/en not_active Ceased
-
2002
- 2002-07-11 PA PA20028550301A patent/PA8550301A1/es unknown
- 2002-07-19 JP JP2003517021A patent/JP2005501054A/ja active Pending
- 2002-07-19 MX MXPA04000978A patent/MXPA04000978A/es active IP Right Grant
- 2002-07-19 RU RU2004102692/04A patent/RU2261861C1/ru not_active IP Right Cessation
- 2002-07-19 DE DE60210778T patent/DE60210778T2/de not_active Expired - Fee Related
- 2002-07-19 IL IL15899802A patent/IL158998A0/xx unknown
- 2002-07-19 AT AT02745749T patent/ATE323677T1/de not_active IP Right Cessation
- 2002-07-19 KR KR10-2004-7001513A patent/KR20040019097A/ko not_active Application Discontinuation
- 2002-07-19 PL PL02368520A patent/PL368520A1/xx not_active Application Discontinuation
- 2002-07-19 HU HU0401573A patent/HUP0401573A3/hu unknown
- 2002-07-19 CZ CZ2004151A patent/CZ2004151A3/cs unknown
- 2002-07-19 BR BR0211670-7A patent/BR0211670A/pt not_active IP Right Cessation
- 2002-07-19 EP EP02745749A patent/EP1412331B1/en not_active Expired - Lifetime
- 2002-07-19 CA CA002451075A patent/CA2451075A1/en not_active Abandoned
- 2002-07-19 US US10/199,755 patent/US7026479B2/en not_active Expired - Fee Related
- 2002-07-19 WO PCT/IB2002/002872 patent/WO2003011829A1/en active IP Right Grant
- 2002-07-19 ES ES02745749T patent/ES2260457T3/es not_active Expired - Lifetime
- 2002-07-19 CN CNA028143256A patent/CN1533378A/zh active Pending
- 2002-07-23 DO DO2002000443A patent/DOP2002000443A/es unknown
- 2002-07-26 PE PE2002000678A patent/PE20030346A1/es not_active Application Discontinuation
- 2002-07-29 UY UY27399A patent/UY27399A1/es not_active Application Discontinuation
- 2002-07-29 EG EG2002070853A patent/EG23204A/xx active
- 2002-07-29 HN HN2002000197A patent/HN2002000197A/es unknown
- 2002-07-31 AR ARP020102914A patent/AR036204A1/es unknown
- 2002-08-01 AP APAP/P/2002/002602A patent/AP1299A/en active
-
2003
- 2003-11-20 ZA ZA200309043A patent/ZA200309043B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA04000978A (es) | 2004-04-20 |
| AR036204A1 (es) | 2004-08-18 |
| EP1412331B1 (en) | 2006-04-19 |
| GB0118752D0 (en) | 2001-09-26 |
| AP1299A (en) | 2004-09-06 |
| ES2260457T3 (es) | 2006-11-01 |
| RU2261861C1 (ru) | 2005-10-10 |
| DE60210778D1 (de) | 2006-05-24 |
| KR20040019097A (ko) | 2004-03-04 |
| EP1412331A1 (en) | 2004-04-28 |
| PE20030346A1 (es) | 2003-04-05 |
| ATE323677T1 (de) | 2006-05-15 |
| PL368520A1 (en) | 2005-04-04 |
| JP2005501054A (ja) | 2005-01-13 |
| US20030100753A1 (en) | 2003-05-29 |
| DE60210778T2 (de) | 2007-01-04 |
| EG23204A (en) | 2004-07-31 |
| US7026479B2 (en) | 2006-04-11 |
| DOP2002000443A (es) | 2003-02-15 |
| AP2002002602A0 (en) | 2002-09-30 |
| WO2003011829A1 (en) | 2003-02-13 |
| HN2002000197A (es) | 2003-02-27 |
| CZ2004151A3 (cs) | 2005-01-12 |
| BR0211670A (pt) | 2004-07-13 |
| ZA200309043B (en) | 2004-11-22 |
| CN1533378A (zh) | 2004-09-29 |
| CA2451075A1 (en) | 2003-02-13 |
| RU2004102692A (ru) | 2005-07-10 |
| PA8550301A1 (es) | 2003-09-05 |
| HUP0401573A2 (hu) | 2005-01-28 |
| IL158998A0 (en) | 2004-05-12 |
| HUP0401573A3 (en) | 2005-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8591701A1 (es) | Derivados de pirrolopirimidina | |
| CL2008003431A1 (es) | Compuestos derivados de nucleosidos 2',4' sustituidos; proceso de preparacion de dichos compuestos; composicion farmaceutica que los comprende; su metodo de preparacion; y su uso para el tratamiento y/o la prevencion de cualquier condicion resultante de una infeccion por vhb, vhc o vih. | |
| ECSP044992A (es) | Inhibidores de la alquín-aril fosfodiesterasa-4 | |
| CY1111693T1 (el) | Αντιιικοι παραγοντες | |
| AR058433A1 (es) | Derivado de 1,1-dioxido de 1,4-benzotiazepina ,procedimiento para su preparacion ,medicamentos que comprenden este compuesto y su uso | |
| AR049681A1 (es) | Macrolidos preparados a partir de actinomicetos. composiciones farmaceuticas | |
| RS50140B (sr) | Postupak za dobijanje perkihinina i njegova upotreba | |
| EA200300050A1 (ru) | Гликопептидфосфонатные производные | |
| YU12103A (sh) | Polimorfni oblici epotilonskog analoga | |
| DE602004008098D1 (de) | Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren | |
| DE60205870D1 (de) | Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil | |
| CY1105039T1 (el) | ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ ΕΝΩΣΕΙΣ ΒΕΝΖΟ[b]ΑΖΕΠΙΝ-2-ΟΝΗΣ | |
| UY27700A1 (es) | Compuestos oxo - azabiclícos. | |
| UY27399A1 (es) | Proceso para la preparación de quinazolinas | |
| SE9901077D0 (sv) | Novel use | |
| EA200701856A1 (ru) | Тетрагидропиридоазепин-8-оны и родственные соединения для лечения шизофрении | |
| HUP0102615A2 (hu) | 2-(2-Klór-fenil)-3,4-dihidro-2H-pirrol-származékok | |
| EA200000431A2 (ru) | Новые замещенные димерные соединения, способ их получения и фармацевтические композиции, содержащие их | |
| ECSP034531A (es) | Derivados sustituidos de c-ciclohexilmetilamina | |
| UY26720A1 (es) | Derivados del pirrol | |
| AR035110A1 (es) | Compuesto derivado de piperazina, uso del mismo para la preparacion de una composicion farmaceutica, composicion farmaceutica que lo comprende y procedimiento para la preparacion de dicho compuesto | |
| DOP2006000240A (es) | Un inhibidor de fosfodiesterasa-4 4-oxo-1-(3-sustituido fenil)-1,4-dihidro-1,8-naftiridin-3-carboxamida y un procedimiento de preparación del mismo | |
| AR025380A1 (es) | Las rutas sinteticas eficientes para la preparacion de los inhibidores de la proteasa del rinovirus. | |
| UY27372A1 (es) | Derivados de bencimidazol 1-aril-2-n, s u o-sustituidos, su uso para la obtención de medicamentos y preparados farmacéuticos que contienen estos derivados | |
| YU83403A (sh) | Korišćenje derivata piridoindolona za spravljanje lekova |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20150126 |